2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Tuesday, September 24, 2019

1:45pm-3:15pm: Identifying healthy Parkin mutation carriers based on sensor-based posturography and gait analysis

J. Prasuhn, M. Borsche, A. Hicks, M. Gögele, C. Egger, C. Kritzinger, L. Langlott, M. Kasten, C. Klein, P. Pramstaller, N. Brüggemann (Lübeck, Germany)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Identifying Incident Cases of Neurodegenerative Parkinsonism in a Large Observational At-Risk Cohort: the PPMI study

L. Chahine, K. Kieburtz, M. Brumm, C. Caspell-Garcia, C. Coffey, A. Siderowf, D. Weintraub, C. Tanner, T. Foroud, D. Galasko, B. Mollenhauer, T. Simuni, K. Marek (Pittsburgh, PA, USA)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Identifying perceptual, motor and cognitive components contributing to the slowness of information processing in Parkinson’s disease and the implication in the quality of life

A. Arroyo, J. Andreo, J. Periañez, G. Lubrini, M. Rios, JP. Romero (Pozuelo de Alarcon, Spain)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Impact of a high-fat diet on the behavior of A53T alpha-Synuclein Parkinson’s disease mice

M. Temmel, V. Niederkofler, R. Rabl, H. Roemer, B. Hutter-Paier (Grambach, Austria)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Impact of fixed or flexible abobotulinumtoxinA injection intervals on patient outcomes: Analyses from a 3-year observational study following patients with cervical dystonia

C. Colosimo, T. Chung, D. Charles, V. Misra, S. Om, P. Maisonobe (Terni, Italy)

Dystonia · Les Muses Terrace, Level 3

1:45pm-3:15pm: Impact of OFF periods on aspects of employment for people with Parkinson’s disease

I. Iresha Abeynayake, L. Marinucci, M. Klingler, C. Kenney (Aardsley, NY, USA)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Impact of overweight and obesity on functional and clinical outcomes of early Parkinson’s disease

R. Kim, JS. Jun (Seoul, Republic of Korea)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Impact of quantitative assessment of parkinsonian symptoms using wearable technology on treatment decisions

C. Thomas, B. Mohamed, M. Silverdale, C. Kobylecki, L. Osborne, R. Saha, P. Bain, D. Heisters, C. Carroll (Cardiff, United Kingdom)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Impaired intracortical inhibition predicts response to medication in Parkinson’s disease patients

SR. Filipović, A. Kačar, S. Milanović, M. Ljubisavljević, VS. Kostić (Beograd, Serbia)

Neurophysiology · Les Muses Terrace, Level 3

1:45pm-3:15pm: Impaired LTP-like plasticity in Parkinson’s Disease can be restored by γ-transcranial alternating current stimulation

A. Guerra, A. Suppa, F. Asci, V. D'Onofrio, V. Sveva, M. Bologna, A. Berardelli (Rome, Italy)

Neurophysiology · Les Muses Terrace, Level 3